Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 16 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

31%

5 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (4)
P 1 (4)
P 2 (3)
P 3 (2)
P 4 (3)

Trial Status

Completed7
Unknown5
Recruiting2
Not Yet Recruiting1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07203755Phase 1Recruiting

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

NCT06621654Phase 1Active Not RecruitingPrimary

Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine

NCT06618196Phase 2Not Yet Recruiting

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

NCT06605755Not ApplicableRecruiting

Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants

NCT04978818Phase 4CompletedPrimary

Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)

NCT05952596Phase 1Unknown

A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults

NCT05457946Phase 2Unknown

Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

NCT03870061Not ApplicableCompleted

Evaluation of an Infant Immunization Encouragement Program in Nigeria

NCT04177485Not ApplicableCompleted

Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda

NCT04073459Phase 2Unknown

Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants

NCT03208101Phase 1Completed

A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults

NCT04056728Phase 4Unknown

A Phase IV Study to Assess the Safety of EupentaTM Inj

NCT03341195Not ApplicableUnknown

Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan

NCT02094833Phase 3Completed

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

NCT01404962Phase 4CompletedPrimary

Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children

NCT00654901Phase 3Completed

Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™

Showing all 16 trials

Research Network

Activity Timeline